Amarin Says Supplement Cos. Can't Tout Its Omega-3 Trial
Amarin Pharma Inc. has accused two supplement makers in California federal court of undercutting the reputation of its U.S. Food and Drug Administration-approved medication Vascepa by relying on its clinical trial...To view the full article, register now.
Already a subscriber? Click here to view full article